Clinical Trials Logo

Morbidity;Newborn clinical trials

View clinical trials related to Morbidity;Newborn.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06087224 Recruiting - Morbidity;Newborn Clinical Trials

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

Start date: March 5, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

NCT ID: NCT05517577 Recruiting - Clinical trials for Knowledge, Attitudes, Practice

An Integrated Community-based Intervention Package in Improving Maternal and Neonatal Health Outcomes

ICBIP-MNH)
Start date: August 20, 2022
Phase: N/A
Study type: Interventional

This study aims to improve maternal, neonatal and infant health outcomes through an integrated community-based intervention package in Jimma Zone, Southwest Ethiopia.

NCT ID: NCT05397678 Recruiting - Morbidity;Newborn Clinical Trials

Trial to Compare BCG-Bulgaria and BCG-Denmark

BCGSTRAIN IV
Start date: October 21, 2022
Phase: Phase 4
Study type: Interventional

The trial will be a two-year outcome assessor-blinded RCT at the maternity ward of Hospital Simão Mendes (HNSM) in urban Bissau, Guinea-Bissau to compare vaccination with Bacillus Calmette-Guérin (BCG) Danish strain (AJ Vaccines, Copenhagen 1331 strain) versus BCG-Bulgaria (BB-NCIPD, BCG-SL 222 Sofia strain) 1:1 in 15,000 infants with respect to mortality, morbidity and case-fatality rate during hospital admission. The trial will also examine the association between BCG strains and BCG skin reaction kinetics and characteristics. As a secondary aim, this large study will be used to further evaluate the role of maternal BCG immune priming for overall health, since there are indications that the maternal BCG scar status influences offspring health outcomes.